#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +8

  • Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Spain

  • Study on the Safety and Effectiveness of AZD0486 Alone or with Other Drugs for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, or Large B-Cell Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Spain

  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Acalabrutinib for Adults with Chronic Lymphocytic Leukemia and Heart Issues

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Italy Poland Spain

  • Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Venetoclax, Ibrutinib, and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Ibrutinib and Obinutuzumab for Patients with Chronic Lymphocytic Leukemia Who Have Not Received Treatment Before

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Portugal